HtmlToText
events dcat week '17 high-level business development meetings, networking opportunities, education programs march 20 - 23, 2017 - new york city, new york dcat week is the premier business development event for companies engaged in and supporting pharmaceutical development and manufacturing. its unique model brings together members for high-level strategic meetings with key decision makers, timely educational programs and important networking opportunities. it is organized by the drug, chemical & associated technologies association (dcat). events bio-europe spring 2017 the premier springtime partnering conference bringing together a “who's who” from biotech, pharma and finance in europe's most innovative biopharma clusters march 20–22, 2017 - ccib convention centre, barcelona, spain bio-europe spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.... generics generics giant teva joins its adversaries’ lobby october, 2016 | by luc watson w hy are the gates of the sheep pen wide open to invite the wolf in? the question may seem exaggerated, but it is raised by the admission of teva pharmaceutical industries into the major american professional organisation of pharmaceutical companies, phrma (pharmaceutical research and manufacturers of america) on 15 july... generics biosimilars become reality in europe and even in the united states, biosimilars start getting approvals. october, 2016 | by jean chaveroux b iosimilars are becoming a reality in the pharmaceutical industry. this is a consequence of many phase iii biosimilar studies having now been completed or nearing conclusion. biosimilar developers have become highly adept at demonstrating biosimilarity with originator products in the clinical setting and regulators – in the eu and various other non-us markets at least – have become seasoned approvers of biosimilar drugs. even the fda is now approaching the regulatory process with more confidence. if the european biosimilars market has now entered a “commercialisation phase”, the us market is not far behind. ... m&a; pharmanetwork’s quarterly pharmaceutical deals insights this issue brings you pharmanetwork’s perspective on deal activity in the bio-pharmaceutical industry. this issue covers q2 - 2016. october 2016 | by jean chaveroux the volume of deals in q2 declined. around 50 deals have been announced by the pharmaceutical industry out of a total of more than 90 within the health industry (pharma, medical devices, etc.). recent events such as brexit have affected the global markets and are likely to have had an impact on the volume of m&as.; however, we have noted an increase in the volume of transactions worth more than one billion dollars. major factors contributing to the success of m&a; are acquisitions at clinical trial phase of new molecules with great potential, combined with the expiration of blockbuster patents (gleevec, crestor, seroquel, zetia...). the increase in value terms of m&a; deals during q2 is mainly thanks to 40 major transactions announced by gilead, abbvie, pfizer, jazz pharmaceutical, mylan and merck, the total value of which came to more than 55 billion dollars. ... outsourcing cmos: customer services a new drive for differentiation october, 2016 | by jean louis briau-geneste the european serialization project has proved to be one of the main factors leading the main cmos to embark upon new customer service strategies. the implementation of the european serialization project and more broadly of the regulatory directives for serialization at the international level require massive investments, the implementation of complex techniques and an extremely rigorous operational organization. the most dynamic cmos have transformed a major regulatory constraint into a sales argument by developing a regulatory service offering adapted to each region of the world. several cmos, such as aesica, recipharm, etc., have made this a major part of their communications strategy. ... events congress and fair interphex 2017, march 21-23, 2017 - javits center, new york, usa all of the state-of-the-art solutions you need to cost effectively develop and manufacture product. for 38 years, interphex is the premier pharmaceutical, biotechnology, and medical device development and manufacturing event where you can “experience science through commercialization”. based in new york, interphex brings over 10,500 global industry professionals and 625+ suppliers together to “learn it, experience it, procure it” through a unique combination of our no cost technical conference, exhibits, demonstrations, partnering opportunities, and networking events to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market. www.interphex.com/home/ social network keep up with us follow @pharmanetwork advertise with us pharmanetwork magazine audience is comprised of the top executives across the pharmaceutical value chain, from r&d;, to production, to finance - we have the top decision makers in the industry. more than 90% of our subscribers hold key positions in the industry. learn more about who reads pharmanetwork magazine and how your brand can connect with that audience mail to: info @ pharmanetwork .com contact us pharmanetwork 1 rue de lille 75007 paris tel: 33 (0)1 42 97 97 97 fax: 33 (0)1 42 97 97 12 mail: info @ pharmanetwork .com pharmanetwork info version 2.0 - 04/2015
Informations Whois
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: PHARMANETWORK.INFO
Registry Domain ID: D189314-LRMS
Registrar WHOIS Server:
Registrar URL: http://www.ovh.com/
Updated Date: 2016-07-18T08:36:09Z
Creation Date: 2001-09-12T18:45:11Z
Registry Expiry Date: 2017-09-12T18:45:11Z
Registrar Registration Expiration Date:
Registrar: OVH sas
Registrar IANA ID: 433
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Reseller:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registry Registrant ID: C171711424-LRMS
Registrant Name: Jean-Louis BRIAU-GENESTE
Registrant Organization:
Registrant Street: 1 rue de lille
Registrant City: Paris
Registrant State/Province:
Registrant Postal Code: F-75007
Registrant Country: FR
Registrant Phone: +33.142979797
Registrant Phone Ext:
Registrant Fax: +33.142979712
Registrant Fax Ext:
Registrant Email: tech@pharmanetwork.com
Registry Admin ID: C171711425-LRMS
Admin Name: Jean-Louis BRIAU-GENESTE
Admin Organization: PHARMANETWORK
Admin Street: 1 rue de Lille
Admin City: Paris
Admin State/Province:
Admin Postal Code: 75007
Admin Country: FR
Admin Phone: +33.142979797
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: info@pharmanetwork.com
Registry Tech ID: C171711425-LRMS
Tech Name: Jean-Louis BRIAU-GENESTE
Tech Organization: PHARMANETWORK
Tech Street: 1 rue de Lille
Tech City: Paris
Tech State/Province:
Tech Postal Code: 75007
Tech Country: FR
Tech Phone: +33.142979797
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email: info@pharmanetwork.com
Registry Billing ID: C171711425-LRMS
Billing Name: Jean-Louis BRIAU-GENESTE
Billing Organization: PHARMANETWORK
Billing Street: 1 rue de Lille
Billing City: Paris
Billing State/Province:
Billing Postal Code: 75007
Billing Country: FR
Billing Phone: +33.142979797
Billing Phone Ext:
Billing Fax:
Billing Fax Ext:
Billing Email: info@pharmanetwork.com
Name Server: DNS200.ANYCAST.ME
Name Server: NS200.ANYCAST.ME
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2017-07-14T02:28:19Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
Access to AFILIAS WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Afilias registry database. The data in this record is provided by Afilias Limited for informational purposes only, and Afilias does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to(a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Afilias reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.
REFERRER http://whois.afilias.info
REGISTRAR Afilias Global Registry Services
SERVERS
SERVER info.whois-servers.net
ARGS pharmanetwork.info
PORT 43
TYPE domain
RegrInfo
DOMAIN
NAME pharmanetwork.info
HANDLE D189314-LRMS
CREATED 2001-12-09
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
DNS200.ANYCAST.ME 46.105.206.200
NS200.ANYCAST.ME 46.105.207.200
OWNER
HANDLE C171711424-LRMS
NAME Jean-Louis BRIAU-GENESTE
ADDRESS
STREET
1 rue de lille
CITY Paris
PCODE F-75007
COUNTRY FR
PHONE +33.142979797
EMAIL tech@pharmanetwork.com
ADMIN
HANDLE C171711425-LRMS
NAME Jean-Louis BRIAU-GENESTE
ORGANIZATION PHARMANETWORK
ADDRESS
STREET
1 rue de Lille
CITY Paris
PCODE 75007
COUNTRY FR
PHONE +33.142979797
EMAIL info@pharmanetwork.com
TECH
HANDLE C171711425-LRMS
NAME Jean-Louis BRIAU-GENESTE
ORGANIZATION PHARMANETWORK
ADDRESS
STREET
1 rue de Lille
CITY Paris
PCODE 75007
COUNTRY FR
PHONE +33.142979797
EMAIL info@pharmanetwork.com
BILLING
HANDLE C171711425-LRMS
NAME Jean-Louis BRIAU-GENESTE
ORGANIZATION PHARMANETWORK
ADDRESS
STREET
1 rue de Lille
CITY Paris
PCODE 75007
COUNTRY FR
PHONE +33.142979797
EMAIL info@pharmanetwork.com
REGISTERED yes
Go to top
pharmanetwork.info rapport :
Visitez le site